Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Jun;45(6):628–636. doi: 10.1136/hrt.45.6.628

Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.

N Edvardsson, S B Olsson
PMCID: PMC482575  PMID: 7259913

Abstract

The right ventricular repolarisation phase was studied electrophysiologically after an injection of 15 mg metoprolol in 16 healthy volunteers. Eight of them were restudied after chronic treatment with 400 mg metoprolol daily for five weeks. The assessment of the repolarisation time included ventricular effective refractory periods, monophasic action potential duration, and the QT interval measured during atrial stimulation at different driving frequencies. The acute administration of 15 mg metoprolol intravenously had no detectable effect on the repolarisation phase, while chronic treatment caused a significant increase of the ventricular effective refractory periods, monophasic action potential duration, and the QT interval during atrial stimulation. Thus the study confirmed the contrasting effect of acute and chronic beta-receptor blockade on the ventricular repolarisation time in man.

Full text

PDF
628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Borg K. O., Carlsson E., EK L., Johnson G., Malmfors T., Regårdh C. G. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):7–23. doi: 10.1111/j.1600-0773.1975.tb03318.x. [DOI] [PubMed] [Google Scholar]
  2. Edvardsson N., Hirsch I., Emanuelsson H., Pontén J., Olsson S. B. Sotalol-induced delayed ventricular repolarization in man. Eur Heart J. 1980 Oct;1(5):335–343. doi: 10.1093/eurheartj/1.5.335. [DOI] [PubMed] [Google Scholar]
  3. Fitzgerald J. D. Beta blocking drugs as anti-arrhythmic agents. Int J Clin Pharmacol Biopharm. 1975 Apr;11(3):235–244. [PubMed] [Google Scholar]
  4. Guss S. B., Kastor J. A., Josephson M. E., Schare D. L. Human ventricular refractoriness. Effects of cycle length, pacing site and atropine. Circulation. 1976 Mar;53(3):450–455. doi: 10.1161/01.cir.53.3.450. [DOI] [PubMed] [Google Scholar]
  5. Harper R. W., Olsson S. B. Effect of mexiletine on conduction of premature ventricular beats in man: a study using monophasic action potential recordings from the right ventricle. Cardiovasc Res. 1979 Jun;13(6):311–319. doi: 10.1093/cvr/13.6.311. [DOI] [PubMed] [Google Scholar]
  6. Olsson B., Brorson L., Harper R., Rydén L. Estimation of ventricular refractoriness in man by the extra stimulus method. Cardiovasc Res. 1977 Jan;11(1):31–38. doi: 10.1093/cvr/11.1.31. [DOI] [PubMed] [Google Scholar]
  7. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Prichard B. N. The use of beta adrenergic blocking drugs in cardiovascular disease. Scott Med J. 1976 Oct;21(4):182–187. doi: 10.1177/003693307602100407. [DOI] [PubMed] [Google Scholar]
  9. Raine A. E., Williams E. M. Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction. Br Heart J. 1976 Aug;38(8):873–874. [PubMed] [Google Scholar]
  10. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  11. Rydén L., Olsson B., Kvasnicka J. Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods. Cardiovasc Res. 1975 Jan;9(1):81–94. doi: 10.1093/cvr/9.1.81. [DOI] [PubMed] [Google Scholar]
  12. Seides S. F., Josephson M. E., Batsford W. P., Weisfogel G. M., Lau S. H., Damato A. N. The electrophysiology of propranolol in man. Am Heart J. 1974 Dec;88(6):733–741. doi: 10.1016/0002-8703(74)90283-x. [DOI] [PubMed] [Google Scholar]
  13. Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs. 1974;7(6):426–461. doi: 10.2165/00003495-197407060-00004. [DOI] [PubMed] [Google Scholar]
  14. Singh B. N., Vaughan Williams E. M. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol. 1970 Aug;39(4):675–687. doi: 10.1111/j.1476-5381.1970.tb09893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Strauss H. C., Bigger J. T., Jr, Hoffman B. F. Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970 Jun;26(6):661–678. doi: 10.1161/01.res.26.6.661. [DOI] [PubMed] [Google Scholar]
  17. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]
  18. Williams E. M., Raine A. E., Cabrera A. A., Whyte J. M. The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits. Cardiovasc Res. 1975 Sep;9(5):579–592. doi: 10.1093/cvr/9.5.579. [DOI] [PubMed] [Google Scholar]
  19. Wit A. L., Hoffman B. F., Rosen M. R. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C. Am Heart J. 1975 Dec;90(6):795–803. doi: 10.1016/0002-8703(75)90471-8. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES